Axogen, Inc. (AXGN): Depreciation & Amortization
$6.66M
Year ended 2025-12-31
$6.49M
Trailing 12 months to 2026-06-30
+33.1%
3-year compound annual growth
+34.2%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.66M | +3.0% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $6.47M | +53.3% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $4.22M | +49.2% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $2.83M | +3.0% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $2.74M | +79.3% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $1.53M | n/a | 2023-03-14, From 2020-01-01 |
| No annual figure between 2014-12-31 and 2020-12-31. | |||
| 2014-12-31 | $153.7K | +93.9% | 2015-03-05, From 2014-01-01 |
| 2013-12-31 | $79.2K | -57.8% | 2015-03-05, From 2013-01-01 |
| 2012-12-31 | $187.7K | -31.4% | 2014-03-06, From 2012-01-01 |
| 2011-12-31 | $273.5K | n/a | 2013-08-07, From 2011-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Axogen, Inc. (AXGN) | 2025-12-31 | $6.66M | +3.0% |
| InMode Ltd. (INMD) | 2025-12-31 | $695.0K | -4.5% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $4.34M | -24.2% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $2.25M | -56.3% |
| Vaso Corp (VASO) | 2025-12-31 | $858.0K | +4.1% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $1.34M | +17.5% |
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $27.18M | +37.6% |
| Iridex Corp (IRIX) | 2026-01-03 | $523.0K | -10.4% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $501.0K | -34.1% |
Compare AXGN, INMD, OM, BLFS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗